Michel L - Search Results

1

Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians.

Roux P, Lions C, Michel L, Cohen J, Mora M, Marcellin F, Spire B, Morel A, Carrieri PM, Karila L; ANRS Methaville Study Group. Roux P, et al. Among authors: michel l. Curr Pharm Des. 2014;20(25):4097-105. doi: 10.2174/13816128113199990623. Curr Pharm Des. 2014. PMID: 24001291 Clinical Trial.

2

Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).

Michel L, Giorgi R, Villes V, Poizot-Martin I, Dellamonica P, Spire B, Protopopescu C, Carrieri MP. Michel L, et al. Drug Alcohol Depend. 2009 Jan 1;99(1-3):96-104. doi: 10.1016/j.drugalcdep.2008.07.007. Epub 2008 Sep 6. Drug Alcohol Depend. 2009. PMID: 18774237

3

Effect of anxiety symptoms on adherence to highly active antiretroviral therapy in HIV-infected women.

Roux P, Carrieri MP, Michel L, Fugon L, Marcellin F, Obadia Y, Spire B. Roux P, et al. Among authors: michel l. J Clin Psychiatry. 2009 Sep;70(9):1328-9. doi: 10.4088/JCP.08l04885. J Clin Psychiatry. 2009. PMID: 19818261 No abstract available.

4

Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention.

Michel L, Carrieri MP, Fugon L, Roux P, Aubin HJ, Lert F, Obadia Y, Spire B; VESPA study group. Michel L, et al. AIDS Care. 2010 Sep;22(9):1136-45. doi: 10.1080/09540121003605039. AIDS Care. 2010. PMID: 20824566

5

Determinants of benzodiazepine use in a representative population of HIV-infected individuals: the role of HIV status disclosure (ANRS-EN12-VESPA study).

Roux P, Fugon L, Michel L, Lert F, Obadia Y, Spire B, Carrieri MP. Roux P, et al. Among authors: michel l. AIDS Care. 2011 Sep;23(9):1163-70. doi: 10.1080/09540121.2011.555738. Epub 2011 May 23. AIDS Care. 2011. PMID: 21562996 Free article.

6

Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy.

Michel L, Jauffret-Roustide M, Blanche J, Maguet O, Calderon C, Cohen J, Carrieri PM; ANRS PRI²DE study group. Michel L, et al. BMC Public Health. 2011 May 27;11:400. doi: 10.1186/1471-2458-11-400. BMC Public Health. 2011. PMID: 21619573 Free PMC article.

7

Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.

Protopopescu C, Raffi F, Brunet-François C, Salmon D, Verdon R, Reboud P, Carrieri MP, Leport C, Spire B, Michel L; APROCO-COPILOTE (ANRS CO8) Study Group. Protopopescu C, et al. Among authors: michel l. Antivir Ther. 2012;17(6):1079-83. doi: 10.3851/IMP2102. Epub 2012 Apr 27. Antivir Ther. 2012. PMID: 22544079

8

Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.

Roux P, Michel L, Cohen J, Mora M, Morel A, Aubertin JF, Desenclos JC, Spire B, Carrieri PM; ANRS Methaville Study Group. Roux P, et al. Among authors: michel l. BMC Public Health. 2012 Jun 28;12:488. doi: 10.1186/1471-2458-12-488. BMC Public Health. 2012. PMID: 22741944 Free PMC article. Clinical Trial.

9

Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial).

Lions C, Carrieri MP, Michel L, Mora M, Marcellin F, Morel A, Spire B, Roux P; Methaville Study Group. Lions C, et al. Among authors: michel l. Drug Alcohol Depend. 2014 Feb 1;135:1-8. doi: 10.1016/j.drugalcdep.2013.10.018. Epub 2013 Oct 31. Drug Alcohol Depend. 2014. PMID: 24268548 Clinical Trial.

10

Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions.

Roux P, Lions C, Michel L, Mora M, Daulouède JP, Marcellin F, Spire B, Morel A, Carrieri PM; ANRS Methaville study group. Roux P, et al. Among authors: michel l. Subst Abuse Treat Prev Policy. 2014 Sep 10;9:37. doi: 10.1186/1747-597X-9-37. Subst Abuse Treat Prev Policy. 2014. PMID: 25209306 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

791 results

Search Page